tailieunhanh - Báo cáo y học: "Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report"

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report | Journal of Medical Case Reports BioMed Central Open Access Case report Lipoprotein glomerulopathy treated with LDL-apheresis Heparin-induced Extracorporeal Lipoprotein Precipitation system a case report Gianpaolo Russi 1 Luciana Furci2 Marco Leonelli2 Riccardo Magistroni2 Nicola Romano1 Paolo Rivasi1 and Alberto Albertazzi2 Address Transfusion Medicine and Immunohaematology Unit Azienda Ospedaliera S Maria Nuova di Reggio Emilia Viale Risorgimento 80 42100 Reggio Emilia Italy and 2Nephrology Dialysis and Transplantation Clinic Azienda Ospedaliero-Universitaria Policlinico di Modena Largo Del Pozzo 71 41100 Modena Italy Email Gianpaolo Russi - Luciana Furci - Marco Leonelli - Riccardo Magistroni - Nicola Romano - Paolo Rivasi - Alberto Albertazzi - Corresponding author Published 2 December 2009 Received 13 November 2008 Journal of Medical Case Reports 2009 3 9311 doi 1752-1947-3-93 I I Accepted 2 December 2009 This article is available from http content 3 1 93 1 1 2009 Russi et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Introduction Lipoprotein glomerulopathy is a glomerulonephritis which was described for the first time by Saito in 1989 and is currently acknowledged as a separate nosological entity. It is histologically characterized by a marked dilatation of the glomerular capillaries and the presence of lipoprotein thrombi in the glomerular lumens. The dyslipidemic profile is similar to that of type III dyslipoproteinemia with Apolipoprotein E values that are often high .